Captrust Financial Advisors Pliant Therapeutics, Inc. Transaction History

Captrust Financial Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$4.11 - $8.75 $2,350 - $5,005	572 Added 1430.0%	612 $5,000
Q1 2022 May 16, 2022	BUY	$7.01 - $14.1 $280 - $564	40 New	40 $0
Q3 2021 Nov 16, 2021	SELL	$16.48 - $28.98 $1,252 - $2,202	-76 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$28.05 - $37.69 $2,131 - $2,864	76 New	76 $2,000

168

63.2M

245K

373K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.